Details for 2021205752
Up to date per 04.04.2026
Actions
Details for 2021205752
Granted/Registered
European Patent
06.04.2022 A
06.03.2024 B1
24.10.2014
US
201462068357 P
22.04.2015
US
201562151384 P
A61K 38/095 20190101AFI20230915BHEP
Owner
Mallinckrodt Pharmaceuticals Ireland LimitedCollege Business & Technology Park Cruiserath, Blanchardstown Dublin 15IE
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
JAMIL, Khurram Pennsylvania, 18940US
PAPPAS, Stephen Chris Texas, 77382US
POTENZIANO, Jim New York, 13901US
Information about Fees